TickerStat.comL'oreal annual shareholders’ equity
2019
2020
2021
2022
2023
2024
2025
L'oreal Shareholders’ Equity Growth & History (OR)
L'oreal's shareholders’ equity was €34.95B for fiscal 2025.
View full L'oreal company overviewL'oreal annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €34.95B | €1.82B | +5.49% |
| 2024 | 2024-12-31 | €33.13B | €4.06B | +13.96% |
| 2023 | 2023-12-31 | €29.07B | €1.90B | +6.98% |
| 2022 | 2022-12-31 | €27.18B | €3.59B | +15.23% |
| 2021 | 2021-12-31 | €23.59B | −€5.41B | −18.65% |
| 2020 | 2020-12-31 | €28.99B | −€426.3M | −1.45% |
| 2019 | 2019-12-31 | €29.42B | — | — |
L'oreal quarterly shareholders’ equity
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €33.84B | €2.66B | +8.54% |
| Q4 2025 | 2025-12-31 | €34.95B | €1.82B | +5.49% |
| Q2 2025 | 2025-06-30 | €31.18B | — | — |
| Q4 2024 | 2024-12-31 | €33.13B | — | — |
L'oreal shareholders’ equity trends
Over the last five fiscal years, L'oreal's shareholders’ equity increased from €28.99B to €34.95B, a change of €5.96B. The latest reported quarter, Q2 2026, shows €33.84B.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review L'oreal source filings ↗Community posts
L’Oréal faces Arizona lawsuit over hair-relaxer safety claims
Arizona sued L’Oréal ($OR-EURONEXT), alleging that the company concealed cancer risks associated with chemical hair relaxers. The state is seeking remedies including damages, penalties and stronger warnings. The allegations concern products ...